Meeting
2017 Genitourinary Cancers Symposium
Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.
Authors
Akhila Ganeshi Wimalasingham
Barts Health NHS Trust St Bartholomew's Hospital, London, United Kingdom
Akhila Ganeshi Wimalasingham , Alfonso Gomez De Liano Lista , Roderick de Bruijn , John B. A. G. Haanen , Bernadett Szabados , Peter Hall , Christian U. Blank , Simon Chowdhury , Thomas Hopkins , Thomas Powles , Axel Bex
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer
Track
Renal Cell Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 514)
DOI
10.1200/JCO.2017.35.6_suppl.514
Abstract #
514
Poster Bd #
G5
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Patient perspectives on cytoreductive nephrectomy after CARMENA.
First Author: Dena Battle
Poster
2016 Genitourinary Cancers Symposium
Initial compared to deferred cytoreductive nephrectomy for metastatic kidney cancer and its association with improved survival in the targeted therapy era.
First Author: Liam Connor Macleod
Poster
2014 ASCO Quality Care Symposium
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
First Author: Lori Wood
Poster
2013 Genitourinary Cancers Symposium
Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer.
First Author: Thomas Powles